Assessing Genomic Aberrations in Cancer Using Microarrays
Author Information
Author(s): Guttman Mitchell, Mies Carolyn, Dudycz-Sulicz Katarzyna, Diskin Sharon J, Baldwin Don A, Stoeckert Christian J Jr., Grant Gregory R
Primary Institution: Penn Center for Bioinformatics, University of Pennsylvania
Hypothesis
Can a new method improve the detection of conserved genomic aberrations across multiple cancer samples?
Conclusion
The Multiple Sample Analysis method effectively identifies significant genomic aberrations in cancer samples at high resolution.
Supporting Evidence
- The method accurately detected known regions of aberration in breast cancer samples.
- MSA identified significant aberrations that single sample methods missed.
- The approach allows for high-resolution mapping of genomic changes.
Takeaway
Researchers developed a new way to find important changes in cancer DNA by looking at many samples together, which helps spot patterns that might be missed in individual samples.
Methodology
The study used a new statistical method called Multiple Sample Analysis to assess genomic aberrations across multiple cancer samples.
Potential Biases
Potential biases include probe-specific hybridization and amplification bias.
Limitations
The method may not detect very large aberrations like whole chromosome gains or losses.
Participant Demographics
The study involved breast cancer samples, including ductal carcinoma in situ and lobular carcinoma in situ.
Statistical Information
P-Value
0.0069
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website